Published in Cancer Weekly, January 16th, 2001
The grant will fund collaborative research between Introgen and Philip J. Tofilon, PhD, The University of Texas M.D. Anderson Cancer Center, in Houston, to help advance the preclinical development of a vector that sensitizes tumor cells to radiotherapy.
The grant entitled "Radiosensitization by Anti-Ras scFv-Expressing Adenovirus" will fund studies in the use of AV1Y28, a modified adenoviral vector that carries a gene encoding a single-chain antibody fragment directed against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.